Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Arrowhead Research Corporation (ARWR)

« Back to company index

ARWR Chatter Timeline

Stock Ticker for ARWR

Most Active Tweeters for ARWR

UserTweets
@battagliame30 33
@fpscod9 18
@pt117cool 16
@truthtracer 15
@joetrader87 13

Recent Tweets for ARWR

fpscod9 @fpscod9
@biotech_batman @BikeRieder $ARWR Hey MD PhD Batman Pajama Boy, You need an internship from NatureDotcom, maybe y… https://t.co/U7RuJCdHT5
October 21st 2019, 6:10pm
fpscod9 @fpscod9
@Jon12508683 $ARWR Please post/link your valuation model, so we all can discuss it as compare to model developed by @BioBoyScout
October 21st 2019, 5:10pm
stockmktgenius @stockmktgenius
$ARWR Arrowhead Pharmaceuticals Top stock up 241% from low. Close: 36.50 VolvsAvg: 0.81 Liq: $40M https://t.co/AeDFICx3eC
October 21st 2019, 5:10pm
YuZhu4 @YuZhu4
RT @BikeRieder: $ARWR AD, Bruce Given in my words: RNAi is wonderful because mother nature has done the experiment. It's a natural occurrin…
October 21st 2019, 1:10pm
Steve_382 @Steve_382
$ARWR How accurate is this number from the Nature article? Johnson & Johnson in New Brunswick, New Jersey, purch… https://t.co/lDe4L45CyS
October 21st 2019, 1:10pm
dispatchtribune @dispatchtribune
Arrowhead Pharmaceuticals’ $ARWR Overweight Rating Reiterated at Piper Jaffray Companies https://t.co/3oxNh3tdpv
October 21st 2019, 10:10am
fpscod9 @fpscod9
@BikeRieder $ARWR Haha, I said the same few weeks ago in regards to RNAi as the natural mechanism of "interference"… https://t.co/RcnbZpsdTq
October 21st 2019, 7:10am
BikeRieder @BikeRieder
$ARWR AD, Bruce Given in my words: RNAi is wonderful because mother nature has done the experiment. It's a natural… https://t.co/ObUiihy17V
October 21st 2019, 7:10am
Quantumup1 @Quantumup1
$ARWR PT raised to $54, Overweight rating reiterated at Piper Jaffray https://t.co/9zusqbA1jT
October 21st 2019, 6:10am
OlympiaReport @OlympiaReport
FY2019 Earnings Estimate for Arrowhead Pharmaceuticals Inc $ARWR Issued By Cantor Fitzgerald https://t.co/QuhT9h9bm6
October 21st 2019, 2:10am
WeekHerald @WeekHerald
FY2019 Earnings Estimate for Arrowhead Pharmaceuticals Inc $ARWR Issued By Cantor Fitzgerald https://t.co/kwHJFqtzcV
October 21st 2019, 2:10am
RatingsNetwork @RatingsNetwork
Cantor Fitzgerald Sets Arrowhead Pharmaceuticals FY2019 Earnings Estimates at $0.67 EPS. https://t.co/8cUeeNvTMi $ARWR #ARWR
October 21st 2019, 2:10am
JanniMore @JanniMore
RT @AjTrader7: IN FRIDAY'S LIVE TRADING WEBINAR RE-CAP FOR 10/18/2019 $ARWR THIS WAS A CRAMER PUMP ON THURSDAY'S SHOW, NO OTHER REASON FOR…
October 21st 2019, 2:10am
jerchess @jerchess
$ARWR Dr J, Spike & friends chart and discuss this name https://t.co/hbCRQlMyKg
October 21st 2019, 1:10am
jerchess @jerchess
@shaab5 probably a small pullback then wait for rsi to cross 80. That’s one way to play it. Let me ask u same question about $ARWR
October 21st 2019, 1:10am
WeekHerald @WeekHerald
Arrowhead Pharmaceuticals $ARWR Earns Overweight Rating from Piper Jaffray Companies https://t.co/xvCK5SWmL5
October 20th 2019, 9:10pm
OlympiaReport @OlympiaReport
Arrowhead Pharmaceuticals $ARWR Earns Overweight Rating from Piper Jaffray Companies https://t.co/gE5D7WZqhu
October 20th 2019, 9:10pm
AmericanBanking @AmericanBanking
Arrowhead Pharmaceuticals’ $ARWR “Overweight” Rating Reiterated at Piper Jaffray Companies https://t.co/fxwSCVHmqs #stocks
October 20th 2019, 9:10pm
biotechw2019 @biotechw2019
$ARWR still grinding a higher high. https://t.co/kunuqiJSlS
October 20th 2019, 7:10pm
iknowtybo @iknowtybo
High-volume breakouts expected for $ARWR this week.
October 20th 2019, 5:10pm
battagliame30 @battagliame30
@truthtracer @joetrader87 New $JNJ + $ARWR 12-dose combo trial is all about HBV-e-negs patients(virologically suppr… https://t.co/n14XNcQiBf
October 20th 2019, 3:10pm
battagliame30 @battagliame30
@truthtracer @joetrader87 If FCs are on there way from e+ patients in $JNJ + $ARWR cohort-12 trial, we might see a… https://t.co/BVbNFtYK22
October 20th 2019, 3:10pm
AjTrader7 @AjTrader7
IN FRIDAY'S LIVE TRADING WEBINAR RE-CAP FOR 10/18/2019 $ARWR THIS WAS A CRAMER PUMP ON THURSDAY'S SHOW, NO OTHER R… https://t.co/65TfM3qpBN
October 20th 2019, 1:10pm
BikeRieder @BikeRieder
@joetrader87 @truthtracer $ARWR got $25 mil milestone payments for first triple combo trial.
October 20th 2019, 4:10am
ConsumerFeed @ConsumerFeed
Arrowhead Pharmaceuticals’ $ARWR Neutral Rating Reaffirmed at Cantor Fitzgerald https://t.co/tLFRIfYwGu
October 20th 2019, 1:10am
truthtracer @truthtracer
@joetrader87 $ARWR Groups that are bottom line oriented, save, extend & create better quality of life~Safely. That’… https://t.co/CJerkJibpM
October 20th 2019, 12:10am
truthtracer @truthtracer
@joetrader87 $ARWR Logically, FC s are the goal which has already been implied. However if the FDA clearly sees a p… https://t.co/Jm4Sf9newA
October 19th 2019, 11:10pm
truthtracer @truthtracer
@joetrader87 $ARWR Specifics would logically inhabit that negotiable space between the FDA & Janssen via agreed upo… https://t.co/kDPIQY0Iqi
October 19th 2019, 11:10pm
battagliame30 @battagliame30
@IonisDisrupts @fpscod9 $ARWR CEO might be more prone to being “HYPERSPECIFIC,” at least from y’day’s Analyst’s Day… https://t.co/wkQh3IRXMp
October 19th 2019, 11:10pm
fpscod9 @fpscod9
@BioBoyScout $ARWR Another CA genius move, ie JNJ3989 partnership with $JNJ considering all the combos needed plus… https://t.co/TXlQrN2aMx
October 19th 2019, 11:10pm
battagliame30 @battagliame30
@BioBoyScout 12 months dosing of $JNJ + $ARWR HBV-combo should provide substantial safety data compared to 3 months dosing, too.
October 19th 2019, 9:10pm
truthtracer @truthtracer
@joetrader87 $ARWR As you might suppose, the interpretation of what constitutes a surrogate endpoint is FDA territo… https://t.co/m2WBlsNVjR
October 19th 2019, 8:10pm
battagliame30 @battagliame30
RT @truthtracer: $ARWR It’s would seem a certainty that accelerated approval is on $JNJ (Janssen’s) radar. https://t.co/hQbkRtuagy…
October 19th 2019, 7:10pm
battagliame30 @battagliame30
@BioBoyScout No doubt we see FCs. Maybe some patients will not need all 12 doses of HBV-combo drug. $JNJ + $ARWR. Great news.
October 19th 2019, 7:10pm
battagliame30 @battagliame30
RT @BioBoyScout: $ARWR big win with the new 3x combo clinical trial for their licensed HBV drug with $JNJ. Very aggressive 12 monthly doses…
October 19th 2019, 7:10pm
battagliame30 @battagliame30
@BioBoyScout 12 month (assuming 12 doses) should allow $JNJ + $ARWR to chose when to stop treatment. Assuming it wi… https://t.co/p0fB35Dg81
October 19th 2019, 7:10pm
BikeRieder @BikeRieder
@truthtracer $ARWR This new trial could trigger a new milestone payment when first patients are dosed! 25-50 mil ???
October 19th 2019, 6:10pm
truthtracer @truthtracer
RT @PersimmonTI: $ARWR $MRK Arrowhead, Merck, HIF-2 & the Nobel Prize in Medicine: https://t.co/0oBp3iDFHb
October 19th 2019, 5:10pm
truthtracer @truthtracer
$ARWR It’s would seem a certainty that accelerated approval is on $JNJ (Janssen’s) radar. https://t.co/hQbkRtuagy… https://t.co/AXOQpD3sFV
October 19th 2019, 3:10pm
BioBoyScout @BioBoyScout
$ARWR big win with the new 3x combo clinical trial for their licensed HBV drug with $JNJ. Very aggressive 12 monthl… https://t.co/2xzsMb6N0O
October 19th 2019, 3:10pm
truthtracer @truthtracer
@ModDarvasBox Post CNBC’s (Mad Money) Jim Cramer’s $ARWR interview w/CEO Chris Anzalone, essentially highlighting t… https://t.co/NceWb6saPx
October 19th 2019, 2:10pm
dailypoliticaln @dailypoliticaln
Arrowhead Pharmaceuticals $ARWR Given Neutral Rating at Cantor Fitzgerald https://t.co/HkrvUT8hDa
October 19th 2019, 2:10pm
TickerReport @TickerReport
Arrowhead Pharmaceuticals $ARWR Given Neutral Rating at Cantor Fitzgerald https://t.co/HrSoHKYoCM
October 19th 2019, 2:10pm
IonisDisrupts @IonisDisrupts
@battagliame30 @fpscod9 $ions Lica results are much cleaner. No fls for one, far fewer overall AEs . $Arwr CEO see… https://t.co/iYtyCh6CLJ
October 19th 2019, 11:10am
TheSliv @TheSliv
RT @btendent: Me thinks, $ARWR is building generational wealth for their shareholders.
October 19th 2019, 11:10am
btendent @btendent
Me thinks, $ARWR is building generational wealth for their shareholders.
October 19th 2019, 10:10am
stocknewstimes @stocknewstimes
Arrowhead Pharmaceuticals $ARWR Reaches New 52-Week High at $37.28 https://t.co/MWqjo09SKW
October 19th 2019, 9:10am
TranscriptDaily @TranscriptDaily
Arrowhead Pharmaceuticals $ARWR Sets New 12-Month High at $37.28 https://t.co/D6KG7xxKtR
October 19th 2019, 9:10am
AmericanBanking @AmericanBanking
Cantor Fitzgerald Reiterates Neutral Rating for Arrowhead Pharmaceuticals $ARWR https://t.co/3ZRGUoBj9A #stocks
October 19th 2019, 8:10am
ZolmaxNews @ZolmaxNews
Arrowhead Pharmaceuticals’ $ARWR Neutral Rating Reiterated at Cantor Fitzgerald https://t.co/a0JqpDbb45
October 19th 2019, 7:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.